Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  199.60
-4.48 (-2.20%)
AAPL  261.73
-13.77 (-5.00%)
AMD  205.94
-7.64 (-3.58%)
BAC  52.52
-1.33 (-2.47%)
GOOG  309.37
-1.96 (-0.63%)
META  649.81
-18.88 (-2.82%)
MSFT  401.84
-2.53 (-0.63%)
NVDA  186.94
-3.11 (-1.64%)
ORCL  156.48
-0.68 (-0.43%)
TSLA  417.07
-11.20 (-2.62%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.